Grigoris Gerotziafas: 3 ASH 2025 Poster Awards for Our Team!
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of the CRSA at Sorbonne University, shared on LinkedIn:
”Three ASH 2025 poster awards for our team!
Proud to announce that three posters presented at the ASH 2025 Annual Meeting (Orlando, December 6–9, 2025) received awards
Abstract 1316: “Fibrin clot shields drive clonal selection of cancer cells: Procoagulant properties and proliferative survival of clot-embedded cancer cells. A novel model of tumor microenvironment remodeling.”
By Noelin Baskaran and Mohammed Baghdadi et al.
Abstract 1302: “Tissue factor bearing microparticles drive thromboinflammation and predict DIC and mortality in sepsis: Results from the ROADMAP-Sepsis study.”
Led by Patrick Van Dreden et al.
Abstract 2687: “Venous thromboembolism in multiple myeloma patients treated with BCMA-directed CAR T-cell therapy: A systematic review and meta-analysis.”
Led by Pedro Henrique Las Casas et al.
This success highlights the strength of our “Cancer Vessels, Biology and Therapeutics” (CaVITE) Research Team — a true dream team at the
Centre de Recherche Saint Antoine”
All from ASH25 featured in Hemostasis Today.
-
Jan 24, 2026, 15:54Nicolas Nesseler on How Common and Serious is Post-Op Bleeding After Heart Transplantation
-
Jan 24, 2026, 15:43Roey Tagansky on Tu Youyou and the Rediscovery That Defeated Malaria
-
Jan 24, 2026, 15:27Mavis Agnes Kisakye on Community Impact at HFU
-
Jan 24, 2026, 15:15Jo Jewell Announces Novartis Foundation and Novo Nordisk Collaboration
-
Jan 24, 2026, 15:02Todd Davenport on The Impacts of Long COVID
-
Jan 24, 2026, 14:47Seth D Ginsberg: Last Month, Something Meaningful Happened in Tokyo
-
Jan 24, 2026, 14:33Heghine Khachatryan on New Insights Into Bleeding Mechanisms in Acquired Hemophilia A
-
Jan 24, 2026, 14:21Mamta Soni Shares Highlights from CBC Chennai 2026
-
Jan 24, 2026, 13:52Larysa Mykhailova on Characterization of Allogeneic Platelet Gel